AEterna Zentaris Inc.

Canaccord Lowers Price Target on AEterna Zentaris Inc (AEZS); Eyes Peeled to Clinical Drivers

AEterna Zentaris (NASDAQ:AEZS) delivered a financial third-quarter report on Tuesday, November 8th that “modestly” underperformed Canaccord analyst Neil Maruoka‘s expectations “on a lighter …

Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Expands Promotion of APIFINY® into Florida

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it is expanding its promotion of APIFINY®, the only cancer-specific, non-PSA blood test available to assess the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts